AGP Executive Report
Last update: 9 hours agoCBD in EU food: The European Food Safety Authority gave its first positive opinion for CBD in food, clearing a CBD oil-based supplement as safe up to 2 mg/day for adults (not pregnant or lactating), paving the way for EU approval under Novel Foods rules. Medical cannabis safety alert: Maine health officials warned patients about contaminated “Deep Sea” cannabis concentrate sold by Ganja World after testing found unsafe butane levels; the product was removed and patients with symptoms were told to contact a clinician. Clinical cannabis outcomes: A 10-year study in chronic low back pain reported medical cannabis was linked to major opioid reductions (about 90%), plus lower pain and disability. Research pipeline: News also highlighted CBD’s potential in ischemic stroke therapy via NRF2 antioxidant activity and angiogenesis pathways, plus a new UMBRAA blinding framework aimed at improving psilocybin trial masking. Access & retail: Illinois’ Terrabis won approval to serve medical cannabis patients at its Grayville dispensary alongside adult-use. Hemp market pressure: American hemp sellers are bracing for a looming ban on most products, calling it devastating.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
